[Diagnostic strategies in disorders of hemostasis]
- PMID: 30193524
[Diagnostic strategies in disorders of hemostasis]
Abstract
Hemostasis is a complicated biological system, where the balance between procoagulation and anticoagulation processes maintains fluidity of blood through intact blood vessels and creates thrombi when it is needed to prevent bleeding from the impaired vessels. The modern model of hemostasis is divided into 2 principal phases, the first being defined as primary hemostasis which involves the platelet-vessel interplay, while the second, defined as secondary hemostasis, mainly involves coagulation factors and surfaces of activated cells. The activation and amplification of the coagulation cascade is regulated by natural inhibitors of coagulation. The blood clots which arise to prevent loss of blood must subsequently be broken down and the compact blood vessel wall must be restored. This process is called fibrinolysis. Bleeding and thromboses are manifestations of the impaired hemostatic balance. Detection of its cause is important for efficient treatment and prevention of the condition. This requires a combined evaluation of the family and personal history, a clinical anamnesis along with the evaluation of laboratory results. It is not reasonable or economical to perform all the available tests of hemostasis at the same time. It is recommendable to proceed from the global to the screening and then special tests and, through the process of elimination, obtain an explanation of the bleeding or prothrombotic phenotypes. The purpose of this report is to provide a brief overview of the principal causes of the hemostatic disorders and the practices which facilitate their diagnosis. Key words: diagnosis of hemorrhagic manifestations - diagnostics of thrombophilias - DIC diagnostics - hemophilia A - thrombopathy - von Willebrand disease.
Similar articles
-
Laboratory hemostasis: from biology to the bench.Clin Chem Lab Med. 2018 Jun 27;56(7):1035-1045. doi: 10.1515/cclm-2017-1205. Clin Chem Lab Med. 2018. PMID: 29455188
-
The pathophysiology of bleeding disorders presenting as abnormal uterine bleeding.Am J Obstet Gynecol. 1996 Sep;175(3 Pt 2):770-7. doi: 10.1016/s0002-9378(96)80083-4. Am J Obstet Gynecol. 1996. PMID: 8828560 Review.
-
[Congenital and acquired bleeding disorders].Vnitr Lek. 2018 Summer;64(5):547-558. Vnitr Lek. 2018. PMID: 30193525 Czech.
-
Clinical evaluation of the patient with bruising and bleeding.J Am Acad Dermatol. 1981 Mar;4(3):348-68. doi: 10.1016/s0190-9622(81)70035-5. J Am Acad Dermatol. 1981. PMID: 7012204 Review.
-
Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.Semin Thromb Hemost. 2005;31(4):426-40. doi: 10.1055/s-2005-916678. Semin Thromb Hemost. 2005. PMID: 16149021
Cited by
-
New Perspectives on the Effect of Dandelion, Its Food Products and Other Preparations on the Cardiovascular System and Its Diseases.Nutrients. 2022 Mar 24;14(7):1350. doi: 10.3390/nu14071350. Nutrients. 2022. PMID: 35405963 Free PMC article. Review.
-
Silk Fibroin-Based Biomaterials for Hemostatic Applications.Biomolecules. 2022 Apr 30;12(5):660. doi: 10.3390/biom12050660. Biomolecules. 2022. PMID: 35625588 Free PMC article. Review.
-
Bioactive Natural Compounds with Antiplatelet and Anticoagulant Activity and Their Potential Role in the Treatment of Thrombotic Disorders.Life (Basel). 2021 Oct 15;11(10):1095. doi: 10.3390/life11101095. Life (Basel). 2021. PMID: 34685464 Free PMC article. Review.
-
The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V.Int J Mol Sci. 2022 Jul 27;23(15):8283. doi: 10.3390/ijms23158283. Int J Mol Sci. 2022. PMID: 35955419 Free PMC article. Review.
-
Applications of Chitosan in Surgical and Post-Surgical Materials.Mar Drugs. 2022 Jun 15;20(6):396. doi: 10.3390/md20060396. Mar Drugs. 2022. PMID: 35736199 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical